Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00737906 · ClinicalTrials.gov registry record · Phase 4
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
A Phase 4 study, sponsored by ArthroCare Corporation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00737906 is a Phase 4 study that was terminated before completion, run by ArthroCare Corporation. The registered enrollment target is 30 participants.
The verdict
NCT00737906, a Phase 4 study, was terminated before completion, sponsored by ArthroCare Corporation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary goal of this post-marketing surveillance study is to assess whether surgical turbinate reduction performed using a Coblation® device is associated with reduced nasal obstruction symptoms.
Interventions
- PROCEDURE Surgical turbinate reduction procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-10 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00737906
The ClinicalTrials.gov registry entry for NCT00737906 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ArthroCare Corporation, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surgical turbinate reduction procedure is the first listed.
NCT00737906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00737906 about?
NCT00737906 is a clinical study titled "Surgical Reduction of the Inferior Turbinates for Nasal Obstruction". The primary goal of this post-marketing surveillance study is to assess whether surgical turbinate reduction performed using a Coblation® device is associated with reduced nasal obstruction symptoms.
What is the current status of trial NCT00737906?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2007-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00737906?
The interventions under investigation include: Surgical turbinate reduction procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00737906?
This trial is sponsored by ArthroCare Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.